Caption Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.68M	Sell	2,074,000 -68,500	-3%	-$217K	0.03%	498
2025 Q4	$7.93M	Buy	+2,142,500	New	+$6.92M	0.05%	391
2025 Q1	–	Sell	-323,800	Closed	-$712K	–	1668
2024 Q4	$712K	Sell	323,800 -45,000	-12%	-$105K	0.01%	995
2024 Q3	$609K	Hold	368,800	–	–	0.01%	895
2024 Q2	$819K	Buy	368,800 +143,800	+64%	+$338K	0.01%	711
2024 Q1	$603K	Hold	225,000	–	–	0.01%	838
2023 Q4	$673K	Sell	225,000 -148,800	-40%	-$193K	0.01%	891
2023 Q3	$366K	Hold	373,800	–	–	0.01%	999
2023 Q2	$520K	Sell	373,800 -473,300	-56%	-$661K	0.01%	812
2023 Q1	$1.35M	Sell	847,100 -916,400	-52%	-$4.73M	0.03%	556
2022 Q4	$11M	Buy	1,763,500 +819,600	+87%	+$5.86M	0.17%	148
2022 Q3	$6.32M	Buy	+943,900	New	+$6.48M	0.09%	272
2022 Q2	–	Sell	-200,000	Closed	-$928K	–	1549
2022 Q1	$928K	Buy	+200,000	New	+$858K	0.01%	1003
2021 Q3	–	Sell	-75,000	Closed	-$1.59M	–	1590
2021 Q2	$1.59M	Buy	+75,000	New	+$1.81M	0.02%	764
2020 Q4	–	Sell	-15,000	Closed	-$558K	–	1059
2020 Q3	$558K	Hold	15,000	–	–	0.01%	747
2020 Q2	$770K	Sell	15,000 -12,000	-44%	-$502K	0.03%	588
2020 Q1	$852K	Sell	27,000 -53,000	-66%	-$2.8M	0.05%	437
2019 Q4	$4.77M	Buy	80,000 +50,000	+167%	+$2.25M	0.16%	172
2019 Q3	$1.1M	Sell	30,000 -75,000	-71%	-$2.97M	0.06%	361
2019 Q2	$4.88M	Buy	+105,000	New	+$4.93M	0.25%	118
2019 Q1	–	Sell	-30,000	Closed	-$1.38M	–	614
2018 Q4	$1.38M	Buy	+30,000	New	+$1.45M	0.11%	224